News & Updates

Show Multimedia Only

Survival benefit with postchemoradiation immunotherapy affirmed

15 Aug 2022 by

Starting immunotherapy after chemotherapy and radiation for unresectable stage III nonsmall cell lung cancer (NSCLC) prolongs overall survival, regardless of patient age, health, and socioeconomic status, according to a large US study.

15 Aug 2022

Mammography screening tied to better breast cancer characteristics, outcomes

15 Aug 2022 by

Regularly attending mammography screening sessions may lead to better breast cancer (BC) characteristics and help improve overall survival (OS), reports a recent Singapore study.

15 Aug 2022

Original New Drug Application Approvals by US FDA (01 - 15 August 2022)

15 Aug 2022

New drug applications approved by US FDA as of 01 - 15 August 2022 which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative Approvals. Supplemental approvals may have occurred since the original approval date.

15 Aug 2022

Fear of recurrence common in cancer survivors, patients

14 Aug 2022

A large number of cancer survivors and patients fear disease recurrence, reports a recent meta-analysis. Healthcare providers should address this issue with their patients and be ready to recommend interventions when needed.

14 Aug 2022

Medical, personal factors affect continuation of active surveillance in men

14 Aug 2022

Men take into consideration both personal and medical factors when deciding to continue active surveillance, reports a recent study.

14 Aug 2022

Aquatic physical therapy boosts outcomes in women with breast cancer

13 Aug 2022

Women with breast cancer may benefit significantly from aquatic physical therapy, which reduces fatigue while also improving quality of life (QoL), reports a recent meta-analysis.

13 Aug 2022

Vincristine may disrupt long-term cardiac function in childhood cancer survivors

13 Aug 2022

In childhood cancer survivors (CCS), treatment with vincristine appears to be linked with global longitudinal strain (GLS) abnormalities over the long-term, a new study has found.

13 Aug 2022